BioSig Technologies selects Access Strategy Partners to accelerate commercial salesProactive Investors • 12/21/21
BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial SalesGlobeNewsWire • 12/21/21
BioSig Technologies expands its clinical footprint in Florida, installs PURE EP System in HCA Healthcare-operated hospitalProactive Investors • 12/16/21
BioSig to Participate in the The Benchmark Company 10th Annual Discovery ConferenceGlobeNewsWire • 11/17/21
BioSig Technologies initiates Artificial Intelligence Development Program with Israel-based TechnionProactive Investors • 11/16/21
BioSig Initiates Artificial Intelligence Development Program with Technion – Israel Institute of TechnologyGlobeNewsWire • 11/16/21
BioSig to Host Live Roundtable Webinar to Discuss Clinical Data Delivered With Its Signal Processing Technology For Arrhythmia CareGlobeNewsWire • 11/11/21
BioSig Technologies installs its PURE EP system at renowned Boston medical centerProactive Investors • 11/09/21
BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in BostonGlobeNewsWire • 11/08/21
BioSig Technologies says its PURE EP System has exceeded its procedural target of 1,500 patient cases in 2021Proactive Investors • 11/01/21
Clinical Data Published in the Journal of Cardiovascular Electrophysiology Could Be Important for This StockBenzinga • 10/13/21
BioSig Technologies says its flagship technology to be featured in a live patient case streamed during the 16th Annual International Symposium on Ventricular ArrhythmiaProactive Investors • 10/12/21
BioSig's PURE EP System to be Featured in a Live Patient Case During Annual International Symposium on Ventricular ArrhythmiasGlobeNewsWire • 10/12/21
BioSig says clinical data acquired by its PURE EP System published in Journal of Cardiovascular ElectrophysiologyProactive Investors • 10/04/21